{
    "code": "02023385",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023385",
    "time": "2021-11-05 06:42:50",
    "許可證字號": "衛署藥輸字第023385號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/02\/19",
    "發證日期": "91\/02\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202338501",
    "中文品名": "備鎮心注射液",
    "英文品名": "PERSANTIN INJECTION 10MG\/2ML",
    "適應症": "取代心肌造影時所需之運動試驗。",
    "劑型": "270注射劑",
    "包裝": "2公撮安瓿 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "DIPYRIDAMOLE",
    "限制項目": "02輸　入",
    "申請商名稱": "1225201100  裕利股份有限公司",
    "申請商地址": "台北市松山區南京東路四段126號10樓，10樓之1-3",
    "主製造廠": [
        {
            "": "SPAIN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412400400",
            "成分名稱": "DIPYRIDAMOLE",
            "含量描述": "",
            "含量": "5.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Persantin Injection-104-12-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023385&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "921216GI-01(Persantin Inj_PI)-110-07-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023385&Seq=018&Type=9"
        },
        {
            "title": "PE 10mg 2ml_PIP009045-008-108-06-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023385&Seq=017&Type=9"
        },
        {
            "title": "020233850005-102-10-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023385&Seq=016&Type=9"
        },
        {
            "title": "921216FA-01(Persantin Inj_Carton)-110-07-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023385&Seq=004&Type=8"
        },
        {
            "title": "PE 10mg 2ml_FBP009046-007-108-06-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023385&Seq=003&Type=8"
        },
        {
            "title": "0202338506___20110705.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023385&Seq=002&Type=8"
        }
    ]
}